Irish tech start-up from UCD wins top prize at prestigious pitching event
An Irish health start-up from University College Dublin (UCD) has won a US pitching competition, scooping a $4,500 (€3,900) prize.
Tech firm Kinesis Health Technologies develops products that help prevent falls in older adults using wearable sensor technologies.
The UCD spin-out was declared overall winner of the Tech Day pitching competition at the 21st International Association of Gerontology and Geriatrics (IAGG) World Congress in San Francisco.
At the World Congress, which takes place every four years, over 6,000 experts in the field of ageing gathered together to share their knowledge on improving the health, welfare, and rights of a growing proportion of the world’s population.
Kinesis pitched against a number of leading start-ups from around the world at the Tech Day event 'Technology and Ageing – Innovation for Independence and Innovation'.
CEO and co-founder of Kinesis Health Technologies, Seamus Small, said that they are "delighted" to have won the competition at such a prestigious international ageing conference.
"After winning the Tech Day Award, This prize provides great recognition for the Kinesis team and provides further external validation of the value and impact of our products to the global ageing care market," he said.
Kinesis was founded in 2013 by Seamus Small and Dr Barry Greene as a spin-out company from the Technology Research for Independent Living (TRIL) Centre, a large ageing research programme, at UCD.
The Enterprise Ireland High-Potential Start-Up (HPSU) has already secured customers for its products in Ireland, UK, US, Canada and Australia, and has partners in place in India, Japan, Germany and The Netherlands.
Dan Maher has recently joined the Board of Kinesis as a non-executive director and advisor.
"Ageing is one of the great global challenges, and innovation is, and will be, essential in bringing measurable impact to this challenge. Kinesis’ technology brings real measurability to one of the most critical factors in ageing, the risk of falls," said Mr Maher.
Kinesis QTUG, a Class I medical device is used by healthcare professionals to improve their ability to identify those patients at risk of falls and to prescribe an intervention, to quantify a patient’s response to therapy and rehabilitation, and to assess patients for neurological disorders.
Last November Kinesis announced that it had closed its first investment round and secured €590,000 from a consortium of private investors and Enterprise Ireland.